Elevance Health (ELV) Non-Current Deferred Tax Liability (2016 - 2025)
Elevance Health (ELV) has disclosed Non-Current Deferred Tax Liability for 17 consecutive years, with $2.3 billion as the latest value for Q3 2025.
- On a quarterly basis, Non-Current Deferred Tax Liability rose 10.66% to $2.3 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $2.3 billion, a 10.66% increase, with the full-year FY2024 number at $4.1 billion, up 11.88% from a year prior.
- Non-Current Deferred Tax Liability was $2.3 billion for Q3 2025 at Elevance Health, up from $2.0 billion in the prior quarter.
- In the past five years, Non-Current Deferred Tax Liability ranged from a high of $4.1 billion in Q4 2024 to a low of $1.8 billion in Q3 2022.
- A 5-year average of $2.4 billion and a median of $2.1 billion in 2024 define the central range for Non-Current Deferred Tax Liability.
- Peak YoY movement for Non-Current Deferred Tax Liability: crashed 30.58% in 2022, then surged 80.05% in 2023.
- Elevance Health's Non-Current Deferred Tax Liability stood at $2.8 billion in 2021, then dropped by 28.16% to $2.0 billion in 2022, then skyrocketed by 80.05% to $3.6 billion in 2023, then increased by 11.88% to $4.1 billion in 2024, then tumbled by 42.97% to $2.3 billion in 2025.
- Per Business Quant, the three most recent readings for ELV's Non-Current Deferred Tax Liability are $2.3 billion (Q3 2025), $2.0 billion (Q2 2025), and $2.1 billion (Q1 2025).